Chapter 3 – Route Selection

[1]  John Andraos,et al.  Unification of Reaction Metrics for Green Chemistry: Applications to Reaction Analysis , 2005 .

[2]  Brian J. Kotecki,et al.  Development of a Scalable Synthesis of Dipeptidyl Peptidase-4 Inhibitor ABT-279 , 2009 .

[3]  J. Engel,et al.  Pharmaceutical substances: Syntheses, patents, applications , 2001 .

[4]  Ivan Marziano,et al.  Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route. , 2006, Chemical reviews.

[5]  Ian W Davies,et al.  Looking Forward in Pharmaceutical Process Chemistry , 2009, Science.

[6]  Lisa Jarvis.  GAIN AND LOSS IN MALARIA WAR , 2008 .

[7]  John Andraos,et al.  Global Green Chemistry Metrics Analysis Algorithm and Spreadsheets: Evaluation of the Material Efficiency Performances of Synthesis Plans for Oseltamivir Phosphate (Tamiflu) as a Test Case , 2009 .

[8]  K. Nicolaou,et al.  Total Synthesis of Taxol. 4. The Final Stages and Completion of the Synthesis , 1995 .

[9]  John D. Hayler,et al.  Key green chemistry research areas—a perspective from pharmaceutical manufacturers , 2007 .

[10]  N. Anderson.  Assessing the Benefits of Direct Isolation Processes , 2004 .

[11]  W. Bornmann,et al.  Total Synthesis of Baccatin III and Taxol , 1996 .

[12]  Peter J. Dunn,et al.  The Chemical Development of the Commercial Route to Sildenafil: A Case History , 2000 .

[13]  A. Chan,et al.  A practical and azide-free synthetic approach to oseltamivir from diethyl D-tartrate. , 2010, The Journal of organic chemistry.

[14]  P. DeShong,et al.  An approach to the stereoselective synthesis of syn- and anti-1,3-diol derivatives. Retention of configuration in the Mitsunobu reaction. , 2002, The Journal of organic chemistry.

[15]  A. Fry.  Synthetic organic electrochemistry , 1989 .

[16]  J. H. Edwards,et al.  Nitrilase-Catalysed Desymmetrisation of 3-Hydroxyglutaronitrile: Preparation of a Statin Side-Chain Intermediate , 2006 .

[17]  E. Delaney,et al.  Use of N-trifluoroacetyl-protected amino acid chlorides in peptide coupling reactions with virtually complete preservation of stereochemistry , 2003 .

[18]  Berkeley W. Cue.  A NEW GAME PLAN: Future success of the chemical enterprise depends upon recognizing and adapting to change , 2005 .

[19]  Scott J. Miller.  In search of peptide-based catalysts for asymmetric organic synthesis. , 2004, Accounts of chemical research.

[20]  N. Anderson.  The Impact of Process Chemists and Engineers on Green Chemistry , 2008 .

[21]  David L. Varie,et al.  Approaches to Assessment, Testing Decisions, and Analytical Determination of Genotoxic Impurities in Drug Substances , 2009 .

[22]  N. Daéid,et al.  Emerging use of isotope ratio mass spectrometry as a tool for discrimination of 3,4-methylenedioxymethamphetamine by synthetic route. , 2008, Analytical chemistry.

[23]  M. Kanai,et al.  Synthetic Strategies for Oseltamivir Phosphate , 2008 .

[24]  S. Danishefsky,et al.  On the synthesis of conformationally modified peptides through isonitrile chemistry: implications for dealing with polypeptide aggregation. , 2011, Journal of the American Chemical Society.

[25]  M. K. O'brien,et al.  Efficient synthesis of AMP579, a novel adenosine A1/A2 receptor agonist. , 2000, The Journal of organic chemistry.

[26]  Scott J. Miller,et al.  A case of remote asymmetric induction in the peptide-catalyzed desymmetrization of a bis(phenol). , 2008, Journal of the American Chemical Society.

[27]  E. Balaraman,et al.  Mitsunobu and related reactions: advances and applications. , 2009, Chemical reviews.

[28]  Junhua Tao,et al.  Recent Advances in Developing Chemoenzymatic Processes for Active Pharmaceutical Ingredients , 2007 .

[29]  Ronald J. Biediger,et al.  First total synthesis of taxol. 2. Completion of the C and D rings , 1994 .

[30]  Andrew Nguyen,et al.  Process Development of 5-Fluoro-3-[3-[4-(5-methoxy-4-pyrimidinyl)-1- piperazinyl]propyl]-1H-indole Dihydrochloride , 1997 .

[31]  A. M. Buswell,et al.  Discovery and Development of an Efficient, Scalable, and Robust Route to the Novel CENP-E Inhibitor GSK923295A , 2010 .

[32]  D. Patience,et al.  Development of a Scalable Synthesis of GSK183390A, a PPAR α/γ Agonist , 2007 .

[33]  Feng Xu,et al.  Highly efficient asymmetric synthesis of sitagliptin. , 2009, Journal of the American Chemical Society.

[34]  Concepción Jiménez-González,et al.  Green Chemistry and Engineering: A Practical Design Approach , 2011 .

[35]  T. Hamada,et al.  Efficient short step synthesis of Corey's tamiflu intermediate. , 2008, Organic letters.

[36]  N. Anderson,et al.  Process Development for the Preparation of a Monopril Intermediate by a Trimethylsilyl-Modified Arbuzov Reaction , 1997 .

[37]  Sarah Everts.  ISOTOPES MARK THE SPOT , 2011 .

[38]  W. O. Moss,et al.  A new approach to the rapid parallel development of four neurokinin antagonists. Part 5. Preparation of zm374979 cyanoacid and selective crystallisation of ZM374979 atropisomers , 2004 .

[39]  Celia Arnaud.  ONE-POT BIODIESEL: SYNTHETIC BIOLOGY: Bacteria make biodiesel directly from glucose and hemicellulose , 2010 .

[40]  Jonathan D. Moseley,et al.  Kepner-Tregoe Decision Analysis as a Tool to Aid Route Selection. Part 1 , 2008 .

[41]  M. Karpf,et al.  Efficient access to oseltamivir phosphate (Tamiflu) via the O-trimesylate of shikimic acid ethyl ester. , 2009, Angewandte Chemie.

[42]  Barry M. Trost,et al.  Atom Economy—A Challenge for Organic Synthesis: Homogeneous Catalysis Leads the Way , 1995 .

[43]  David Weiner,et al.  An Enzyme Library Approach to Biocatalysis: Development of Nitrilases for Enantioselective Production of Carboxylic Acid Derivatives , 2002 .

[44]  N. Meanwell,et al.  Regioselective monobenzoylation of unsymmetrical piperazines. , 2000, The Journal of organic chemistry.

[45]  P. Baran,et al.  Total synthesis of marine natural products without using protecting groups , 2007, Nature.

[46]  K. Sanderson.  Chemistry: It's not easy being green , 2011, Nature.

[47]  Paul N. Devine,et al.  Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture , 2010, Science.

[48]  T. Foderaro,et al.  Research and Development of a Second-Generation Process for Oseltamivir Phosphate, Prodrug for a Neuraminidase Inhibitor , 2004 .

[49]  J. Tolle,et al.  A Convergent Process for the Preparation of Adamantane 11-β-HSD-1 Inhibitors , 2008 .

[50]  Stephen K. Ritter,et al.  GREENING UP PROCESS CHEMISTRY , 2010 .

[51]  H. Weinmann,et al.  Trichloroisocyanuric Acid: A Safe and Efficient Oxidant , 2002 .

[52]  R. Hanson.  Stereoselective Enzymatic Synthesis of Intermediates Used for Antihypertensive, Antiinfective, and Anticancer Compounds , 2007 .

[53]  Ann M. Thayer,et al.  MAKING PEPTIDES AT LARGE SCALE: EFFICIENT SYNTHESIS is helping to renew interest in the peptide drug market , 2011 .

[54]  J. Woodley,et al.  Guidelines and Cost Analysis for Catalyst Production in Biocatalytic Processes , 2011 .

[55]  Paige Morse,et al.  PHTHALATES FACE MURKY FUTURE , 2011 .

[56]  S. Ritter.  RACE TO THE PUMP , 2011 .

[57]  M. Natchus,et al.  The Pinene Path to Taxanes. 6. A Concise Stereocontrolled Synthesis of Taxol , 1997 .

[58]  John Whittall,et al.  Practical methods for biocatalysis and biotransformations , 2009 .

[59]  Michael Reilly,et al.  Concise, enantiospecific synthesis of (3S, 4R)-3-amino-4-ethylpiperidine as partner to a non-fluoroquinolone nucleus , 2003 .

[60]  Duane R. Romer,et al.  Development of Manufacturing Processes for a New Family of 2,6-Dihaloaryl 1,2,4-Triazole Insecticides , 2009 .

[61]  Ann M. Thayer.  CUSTOM CHEMICALS: Slowly recovering in 2010, contract manufacturers envision a PATH TOWARD GROWTH by responding to marketplace shifts , 2011 .

[62]  P. Hodge,et al.  Protective groups in organic synthesis , 1981 .

[63]  Roger A. Sheldon,et al.  The E Factor: fifteen years on , 2007 .

[64]  Barbara J. Sitter,et al.  Evaluation of Kilogram-Scale Sonagashira, Suzuki, and Heck Coupling Routes to Oncology Candidate CP-724,714 , 2005 .

[65]  B. Feringa,et al.  Catalytic enantioselective synthesis of (-)-prostaglandin E1 methyl ester based on a tandem 1,4-addition-aldol reaction. , 2002, The Journal of organic chemistry.

[66]  H. Tabata.  Paclitaxel production by plant-cell-culture technology. , 2004, Advances in biochemical engineering/biotechnology.

[67]  Jasmine L. Gallaher,et al.  Computational Design of an Enzyme Catalyst for a Stereoselective Bimolecular Diels-Alder Reaction , 2010, Science.

[68]  K. Sharpless,et al.  Preparation of 5-substituted 1H-tetrazoles from nitriles in water. , 2001, The Journal of organic chemistry.

[69]  Tomas Hudlicky,et al.  Design Constraints in Practical Syntheses of Complex Molecules: Current Status, Case Studies with Carbohydrates and Alkaloids, and Future Perspectives. , 1996, Chemical reviews.

[70]  N. Turner,et al.  A highly efficient synthesis of telaprevir by strategic use of biocatalysis and multicomponent reactions. , 2010, Chemical communications.

[71]  James E. Leresche,et al.  Chemocatalysis and Biocatalysis (Biotransformation): Some Thoughts of a Chemist and of a Biotechnologist , 2006 .

[72]  M. de Rosa,et al.  A microbiological-chemical strategy to produce chondroitin sulfate A,C. , 2011, Angewandte Chemie.

[73]  Cheryl Hogue.  GREEN CLAIMS: Federal Trade Commission proposes to tighten ECO-MARKETING guidelines , 2010 .

[74]  T. Lindberg.  Strategies and Tactics in Organic Synthesis , 1993 .

[75]  B. Bray.  Large-scale manufacture of peptide therapeutics by chemical synthesis , 2003, Nature Reviews Drug Discovery.

[76]  I. Willner,et al.  Cover Picture: Increasing the Complexity of Periodic Protein Nanostructures by the Rolling‐Circle‐Amplified Synthesis of Aptamers (Angew. Chem. Int. Ed. 1/2008) , 2008 .

[77]  N. Sach,et al.  Development of Scalable Syntheses of Selective PI3K inhibitors , 2011 .

[78]  P. Nichols,et al.  Synthesis of methyl-1-(tert-butoxycarbonylamino)-2-vinylcyclopropanecarboxylate via a Hofmann rearrangement utilizing trichloroisocyanuric acid as an oxidant. , 2011, The Journal of organic chemistry.

[79]  D. MacMillan,et al.  Collective synthesis of natural products by means of organocascade catalysis , 2011, Nature.

[80]  Albert S. Matlack,et al.  Introduction to Green Chemistry , 2022 .

[81]  J. Hawkins,et al.  Asymmetric catalysis in the pharmaceutical industry. , 2004, Angewandte Chemie.

[82]  Jieping Zhu,et al.  Aziridinium from N,N-dibenzyl serine methyl ester: synthesis of enantiomerically pure beta-amino and alpha,beta-diamino esters. , 2006, Organic letters.

[83]  Vesna Mitchell,et al.  Development of a Biocatalytic Process as an Alternative to the (−)-DIP-Cl-Mediated Asymmetric Reduction of a Key Intermediate of Montelukast , 2010 .

[84]  J. Tao,et al.  Enzyme and Process Development for Production of Nicotinamide , 2011 .